25 XP   0   0   10

Atreca Inc
Buy, Hold or Sell?

Let's analyse Atreca together

PenkeI guess you are interested in Atreca Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Atreca Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Atreca Inc

I send you an email if I find something interesting about Atreca Inc.

Quick analysis of Atreca (30 sec.)










What can you expect buying and holding a share of Atreca? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
50.0%

What is your share worth?

Current worth
$2.03
Expected worth in 1 year
$-5.98
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
$-8.01
Return On Investment
-9,886.9%

For what price can you sell your share?

Current Price per Share
$0.08
Expected price per share
$0.052 - $0.2301
How sure are you?
50%

1. Valuation of Atreca (5 min.)




Live pricePrice per Share (EOD)

$0.08

Intrinsic Value Per Share

$-26.44 - $-22.91

Total Value Per Share

$-24.40 - $-20.88

2. Growth of Atreca (5 min.)




Is Atreca growing?

Current yearPrevious yearGrowGrow %
How rich?$78.4m$154.9m-$76.5m-97.6%

How much money is Atreca making?

Current yearPrevious yearGrowGrow %
Making money-$90.5m-$109.3m$18.8m20.8%
Net Profit Margin-11,756.5%-12,846.8%--

How much money comes from the company's main activities?

3. Financial Health of Atreca (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#419 / 1011

Most Revenue
#518 / 1011

Most Profit
#962 / 1011

Most Efficient
#943 / 1011

What can you expect buying and holding a share of Atreca? (5 min.)

Welcome investor! Atreca's management wants to use your money to grow the business. In return you get a share of Atreca.

What can you expect buying and holding a share of Atreca?

First you should know what it really means to hold a share of Atreca. And how you can make/lose money.

Speculation

The Price per Share of Atreca is $0.081. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Atreca.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Atreca, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.03. Based on the TTM, the Book Value Change Per Share is $-2.00 per quarter. Based on the YOY, the Book Value Change Per Share is $-2.27 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Atreca.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-2.52-3,107.9%-2.52-3,107.9%-2.85-3,514.0%-2.07-2,557.1%-1.85-2,278.4%
Usd Book Value Change Per Share-2.00-2,471.7%-2.00-2,471.7%-2.27-2,800.5%0.70865.3%0.34418.0%
Usd Dividend Per Share0.000.0%0.000.0%0.0226.9%0.0112.7%0.0110.6%
Usd Total Gains Per Share-2.00-2,471.7%-2.00-2,471.7%-2.25-2,773.6%0.71878.0%0.35428.6%
Usd Price Per Share0.80-0.80-3.03-7.09-5.91-
Price to Earnings Ratio-0.32--0.32--1.06--3.47--2.90-
Price-to-Total Gains Ratio-0.40--0.40--1.35-4.45-4.45-
Price to Book Ratio0.39-0.39-0.75-1.38-1.15-
Price-to-Total Gains Ratio-0.40--0.40--1.35-4.45-4.45-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.081
Number of shares12345
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share-2.000.70
Usd Total Gains Per Share-2.000.71
Gains per Quarter (12345 shares)-24,715.788,779.56
Gains per Year (12345 shares)-98,863.1335,118.24
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-98863-988735103460935108
20-197726-19773610196921770226
30-296589-2965991529103826105344
40-395453-3954622038138434140462
50-494316-4943252548173043175580
60-593179-5931883058207652210698
70-692042-6920513567242260245816
80-790905-7909144077276869280934
90-889768-8897774587311478316052
100-988631-9886405096346086351170

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.06.00.00.0%0.06.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%3.03.00.050.0%3.03.00.050.0%
Dividend per Share0.00.01.00.0%2.00.01.066.7%3.00.02.060.0%3.00.03.050.0%3.00.03.050.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%3.03.00.050.0%3.03.00.050.0%

Fundamentals of Atreca

About Atreca Inc

Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-101 product candidate reacts in vitro with a majority of human ovarian, non-small cell lung, colorectal, and breast cancer samples from multiple patients; and ATRC-501/MAM01, that targets the circumsporozoite protein of Plasmodium falciparum for the treatment of malaria. Its products in pre-clinical stage include APN-497444, an antibody drug conjugate (ADC) against a novel tumor glycan target; and APN-346958, a CD3 bispecific T-cell engager against an RNA-binding protein target. It has a collaboration and license agreement with Xencor, Inc. for research, development, and commercialization of novel CD3 bispecific antibodies in oncology; licensing agreement with the Bill & Melinda Gates Medical Research Institute for the development and commercialization of MAM01/ATRC-501 for the prevention of malaria. The company was incorporated in 2010 and is based in San Carlos, California.

Fundamental data was last updated by Penke on 2024-04-11 01:58:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Atreca Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Atreca earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Atreca to the Biotechnology industry mean.
  • A Net Profit Margin of -11,756.5% means that $-117.56 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Atreca Inc:

  • The MRQ is -11,756.5%. The company is making a huge loss. -2
  • The TTM is -11,756.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-11,756.5%TTM-11,756.5%0.0%
TTM-11,756.5%YOY-12,846.8%+1,090.3%
TTM-11,756.5%5Y-6,829.3%-4,927.2%
5Y-6,829.3%10Y-5,691.1%-1,138.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-11,756.5%-196.1%-11,560.4%
TTM-11,756.5%-211.9%-11,544.6%
YOY-12,846.8%-277.7%-12,569.1%
5Y-6,829.3%-432.9%-6,396.4%
10Y-5,691.1%-599.3%-5,091.8%
1.1.2. Return on Assets

Shows how efficient Atreca is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Atreca to the Biotechnology industry mean.
  • -58.4% Return on Assets means that Atreca generated $-0.58 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Atreca Inc:

  • The MRQ is -58.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -58.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-58.4%TTM-58.4%0.0%
TTM-58.4%YOY-54.6%-3.7%
TTM-58.4%5Y-42.1%-16.3%
5Y-42.1%10Y-47.8%+5.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-58.4%-13.3%-45.1%
TTM-58.4%-12.7%-45.7%
YOY-54.6%-11.8%-42.8%
5Y-42.1%-14.0%-28.1%
10Y-47.8%-15.9%-31.9%
1.1.3. Return on Equity

Shows how efficient Atreca is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Atreca to the Biotechnology industry mean.
  • -115.5% Return on Equity means Atreca generated $-1.15 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Atreca Inc:

  • The MRQ is -115.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -115.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-115.5%TTM-115.5%0.0%
TTM-115.5%YOY-70.6%-44.9%
TTM-115.5%5Y-58.0%-57.4%
5Y-58.0%10Y-48.4%-9.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-115.5%-16.9%-98.6%
TTM-115.5%-16.0%-99.5%
YOY-70.6%-15.1%-55.5%
5Y-58.0%-19.7%-38.3%
10Y-48.4%-20.5%-27.9%

1.2. Operating Efficiency of Atreca Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Atreca is operating .

  • Measures how much profit Atreca makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Atreca to the Biotechnology industry mean.
  • An Operating Margin of -13,479.1% means the company generated $-134.79  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Atreca Inc:

  • The MRQ is -13,479.1%. The company is operating very inefficient. -2
  • The TTM is -13,479.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-13,479.1%TTM-13,479.1%0.0%
TTM-13,479.1%YOY-13,371.9%-107.2%
TTM-13,479.1%5Y-7,291.9%-6,187.2%
5Y-7,291.9%10Y-6,076.6%-1,215.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-13,479.1%-290.9%-13,188.2%
TTM-13,479.1%-224.4%-13,254.7%
YOY-13,371.9%-288.3%-13,083.6%
5Y-7,291.9%-479.5%-6,812.4%
10Y-6,076.6%-625.2%-5,451.4%
1.2.2. Operating Ratio

Measures how efficient Atreca is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 136.85 means that the operating costs are $136.85 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Atreca Inc:

  • The MRQ is 136.852. The company is inefficient in keeping operating costs low. -1
  • The TTM is 136.852. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ136.852TTM136.8520.000
TTM136.852YOY129.706+7.146
TTM136.8525Y73.266+63.586
5Y73.26610Y61.055+12.211
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ136.8523.110+133.742
TTM136.8523.266+133.586
YOY129.7063.783+125.923
5Y73.2665.657+67.609
10Y61.0557.783+53.272

1.3. Liquidity of Atreca Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Atreca is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.79 means the company has $4.79 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Atreca Inc:

  • The MRQ is 4.789. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.789. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.789TTM4.7890.000
TTM4.789YOY7.241-2.452
TTM4.7895Y14.838-10.049
5Y14.83810Y14.308+0.530
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.7893.905+0.884
TTM4.7894.212+0.577
YOY7.2415.337+1.904
5Y14.8386.062+8.776
10Y14.3086.401+7.907
1.3.2. Quick Ratio

Measures if Atreca is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Atreca to the Biotechnology industry mean.
  • A Quick Ratio of 7.02 means the company can pay off $7.02 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Atreca Inc:

  • The MRQ is 7.017. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 7.017. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ7.017TTM7.0170.000
TTM7.017YOY8.263-1.246
TTM7.0175Y17.680-10.663
5Y17.68010Y17.954-0.274
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.0173.572+3.445
TTM7.0174.001+3.016
YOY8.2635.364+2.899
5Y17.6806.009+11.671
10Y17.9546.287+11.667

1.4. Solvency of Atreca Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Atreca assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Atreca to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.49 means that Atreca assets are financed with 49.4% credit (debt) and the remaining percentage (100% - 49.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Atreca Inc:

  • The MRQ is 0.494. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.494. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.494TTM0.4940.000
TTM0.494YOY0.226+0.269
TTM0.4945Y0.183+0.312
5Y0.18310Y0.580-0.397
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4940.336+0.158
TTM0.4940.334+0.160
YOY0.2260.271-0.045
5Y0.1830.366-0.183
10Y0.5800.389+0.191
1.4.2. Debt to Equity Ratio

Measures if Atreca is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Atreca to the Biotechnology industry mean.
  • A Debt to Equity ratio of 97.7% means that company has $0.98 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Atreca Inc:

  • The MRQ is 0.977. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.977. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.977TTM0.9770.000
TTM0.977YOY0.291+0.686
TTM0.9775Y0.296+0.681
5Y0.29610Y0.247+0.049
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9770.382+0.595
TTM0.9770.397+0.580
YOY0.2910.341-0.050
5Y0.2960.432-0.136
10Y0.2470.465-0.218

2. Market Valuation of Atreca Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Atreca generates.

  • Above 15 is considered overpriced but always compare Atreca to the Biotechnology industry mean.
  • A PE ratio of -0.32 means the investor is paying $-0.32 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Atreca Inc:

  • The EOD is -0.032. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.318. Based on the earnings, the company is expensive. -2
  • The TTM is -0.318. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.032MRQ-0.318+0.286
MRQ-0.318TTM-0.3180.000
TTM-0.318YOY-1.065+0.746
TTM-0.3185Y-3.474+3.156
5Y-3.47410Y-2.895-0.579
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.032-2.262+2.230
MRQ-0.318-2.599+2.281
TTM-0.318-2.674+2.356
YOY-1.065-4.133+3.068
5Y-3.474-6.258+2.784
10Y-2.895-6.171+3.276
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Atreca Inc:

  • The EOD is -0.038. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.379. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.379. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.038MRQ-0.379+0.341
MRQ-0.379TTM-0.3790.000
TTM-0.379YOY-1.212+0.833
TTM-0.3795Y-3.966+3.587
5Y-3.96610Y-3.305-0.661
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.038-2.913+2.875
MRQ-0.379-3.275+2.896
TTM-0.379-3.508+3.129
YOY-1.212-5.620+4.408
5Y-3.966-8.306+4.340
10Y-3.305-8.854+5.549
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Atreca is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.39 means the investor is paying $0.39 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Atreca Inc:

  • The EOD is 0.040. Based on the equity, the company is cheap. +2
  • The MRQ is 0.394. Based on the equity, the company is cheap. +2
  • The TTM is 0.394. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.040MRQ0.394-0.354
MRQ0.394TTM0.3940.000
TTM0.394YOY0.751-0.357
TTM0.3945Y1.377-0.983
5Y1.37710Y1.148+0.230
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.0401.858-1.818
MRQ0.3942.090-1.696
TTM0.3942.091-1.697
YOY0.7512.866-2.115
5Y1.3773.488-2.111
10Y1.1483.836-2.688
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Atreca Inc.

3.1. Institutions holding Atreca Inc

Institutions are holding 24.546% of the shares of Atreca Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Boxer Capital LLC5.55810.0145220233300
2023-12-31Baker Bros Advisors LP5.49540.00332177499-1355261-38.3627
2023-12-31Bill & Melinda Gates Foundation2.30330.13291264200
2023-12-31Vanguard Group Inc2.29480909300-419623-31.5762
2023-12-31BlackRock Inc1.61010637974-547684-46.1924
2023-09-30Redmile Group, LLC1.11710.005544265300
2023-12-31Aisling Capital Management LP0.97830.015338765300
2023-12-31Renaissance Technologies Corp0.89850.0001356024141004.1237
2023-12-31Geode Capital Management, LLC0.745702954713254812.3793
2023-12-31HRT FINANCIAL LLC0.5220.00022068422068420
2023-09-30LAURION CAPITAL MANAGEMENT LP0.36040.0002142824-286352-66.7213
2023-12-31Ensign Peak Advisors Inc0.2657010528300
2023-12-31Susquehanna International Group, LLP0.264301047121047120
2023-12-31Goldman Sachs Group Inc0.23130916622150730.6564
2023-12-31Millennium Management LLC0.23080914473502362.0711
2023-12-31State Street Corporation0.2254089320-2200-2.4038
2023-12-31Bridgeway Capital Management, LLC0.18930.000275000-75000-50
2023-12-31Northern Trust Corp0.149305916800
2023-12-31Barclays PLC0.119804748700
2023-12-31Acadian Asset Management LLC0.111304411000
Total 23.67090.17139379404-2271388-24.2%

3.2. Funds holding Atreca Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.99240.000139322800
2024-01-31Fidelity Extended Market Index0.51110.000220252700
2023-09-30BlackRock Extended Mkt Composite0.2140.00028480400
2023-12-31Bridgeway Ultra-Small Company Market0.18930.005375000-75000-50
2023-12-31BlackRock Extended Equity Market K0.18670.000173984-149-0.201
2024-02-29iShares Micro-Cap ETF0.15840.00186277000
2024-01-31Fidelity Total Market Index0.093203691300
2024-01-31Fidelity Series Total Market Index0.080703197700
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.06120.00012424400
2024-02-29Schwab Total Stock Market Index0.057902295900
2023-12-31Northern Trust Extended Eq Market Idx0.05460.00012163400
2023-12-31NT Ext Equity Mkt Idx Fd - L0.05460.00012163400
2023-10-31Vanguard Instl Ttl Stck Mkt Idx Tr0.053021020-884450-97.6786
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.04910.000119471370.1904
2023-12-31BlackRock U.S. Equity Market F0.0423016757300.1794
2024-01-31Spartan Total Market Index Pool E0.031401244500
2023-12-31Fidelity VIP Disciplined Small Cap Init0.02970.00041177500
2024-01-31Fidelity Nasdaq Composite Index0.028401127300
2023-12-31SSgA U.S. Extended Market Index Class I0.02830.00011120000
2024-02-29State St US Extended Mkt Indx NL Cl C0.02830.00021120000
Total 2.94460.00881166815-959532-82.2%

3.3. Insider Transactions

Insiders are holding 2.738% of the shares of Atreca Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-10-19Bros. Advisors Lp BakerSELL2747390.4
2023-08-02Phillips CourtneySELL40760.95
2023-08-02Tito SerafiniSELL54870.95

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Atreca Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---2.002-2.0020%-2.268+13%0.701-386%0.339-691%
Book Value Per Share--2.0322.0320%4.034-50%4.056-50%3.135-35%
Current Ratio--4.7894.7890%7.241-34%14.838-68%14.308-67%
Debt To Asset Ratio--0.4940.4940%0.226+119%0.183+171%0.580-15%
Debt To Equity Ratio--0.9770.9770%0.291+236%0.296+230%0.247+296%
Dividend Per Share----0%0.022-100%0.010-100%0.009-100%
Eps---2.517-2.5170%-2.846+13%-2.071-18%-1.845-27%
Free Cash Flow Per Share---2.114-2.1140%-2.500+18%-1.809-14%-1.622-23%
Free Cash Flow To Equity Per Share---2.013-2.0130%-2.358+17%0.220-1014%0.218-1026%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---22.913--------
Intrinsic Value_10Y_min---26.436--------
Intrinsic Value_1Y_max---1.918--------
Intrinsic Value_1Y_min---2.307--------
Intrinsic Value_3Y_max---6.051--------
Intrinsic Value_3Y_min---7.269--------
Intrinsic Value_5Y_max---10.532--------
Intrinsic Value_5Y_min---12.562--------
Market Cap3111137.100-894%30913709.09430913709.0940%116379573.000-73%272357804.819-89%226964837.349-86%
Net Profit Margin---117.565-117.5650%-128.468+9%-68.293-42%-56.911-52%
Operating Margin---134.791-134.7910%-133.719-1%-72.919-46%-60.766-55%
Operating Ratio--136.852136.8520%129.706+6%73.266+87%61.055+124%
Pb Ratio0.040-889%0.3940.3940%0.751-48%1.377-71%1.148-66%
Pe Ratio-0.032+90%-0.318-0.3180%-1.065+235%-3.474+992%-2.895+810%
Price Per Share0.081-889%0.8010.8010%3.030-74%7.090-89%5.909-86%
Price To Free Cash Flow Ratio-0.038+90%-0.379-0.3790%-1.212+220%-3.966+947%-3.305+772%
Price To Total Gains Ratio-0.040+90%-0.400-0.4000%-1.349+237%4.446-109%4.446-109%
Quick Ratio--7.0177.0170%8.263-15%17.680-60%17.954-61%
Return On Assets---0.584-0.5840%-0.546-6%-0.421-28%-0.478-18%
Return On Equity---1.155-1.1550%-0.706-39%-0.580-50%-0.484-58%
Total Gains Per Share---2.002-2.0020%-2.247+12%0.711-382%0.347-677%
Usd Book Value--78406000.00078406000.0000%154929000.000-49%155872000.000-50%120465500.000-35%
Usd Book Value Change Per Share---2.002-2.0020%-2.268+13%0.701-386%0.339-691%
Usd Book Value Per Share--2.0322.0320%4.034-50%4.056-50%3.135-35%
Usd Dividend Per Share----0%0.022-100%0.010-100%0.009-100%
Usd Eps---2.517-2.5170%-2.846+13%-2.071-18%-1.845-27%
Usd Free Cash Flow---81606000.000-81606000.0000%-96010000.000+18%-69552400.000-15%-62372500.000-24%
Usd Free Cash Flow Per Share---2.114-2.1140%-2.500+18%-1.809-14%-1.622-23%
Usd Free Cash Flow To Equity Per Share---2.013-2.0130%-2.358+17%0.220-1014%0.218-1026%
Usd Market Cap3111137.100-894%30913709.09430913709.0940%116379573.000-73%272357804.819-89%226964837.349-86%
Usd Price Per Share0.081-889%0.8010.8010%3.030-74%7.090-89%5.909-86%
Usd Profit---90525000.000-90525000.0000%-109326000.000+21%-78322000.000-13%-69856166.667-23%
Usd Revenue--770000.000770000.0000%851000.000-10%1021600.000-25%851333.333-10%
Usd Total Gains Per Share---2.002-2.0020%-2.247+12%0.711-382%0.347-677%
 EOD+3 -5MRQTTM+0 -0YOY+16 -195Y+2 -3310Y+3 -32

4.2. Fundamental Score

Let's check the fundamental score of Atreca Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.032
Price to Book Ratio (EOD)Between0-10.040
Net Profit Margin (MRQ)Greater than0-117.565
Operating Margin (MRQ)Greater than0-134.791
Quick Ratio (MRQ)Greater than17.017
Current Ratio (MRQ)Greater than14.789
Debt to Asset Ratio (MRQ)Less than10.494
Debt to Equity Ratio (MRQ)Less than10.977
Return on Equity (MRQ)Greater than0.15-1.155
Return on Assets (MRQ)Greater than0.05-0.584
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Atreca Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.964
Ma 20Greater thanMa 500.085
Ma 50Greater thanMa 1000.189
Ma 100Greater thanMa 2000.205
OpenGreater thanClose0.075
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Net Debt  -114,357-43,544-157,90197,116-60,785-33,961-94,746127,80233,056



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets155,030
Total Liabilities76,624
Total Stockholder Equity78,406
 As reported
Total Liabilities 76,624
Total Stockholder Equity+ 78,406
Total Assets = 155,030

Assets

Total Assets155,030
Total Current Assets78,026
Long-term Assets77,004
Total Current Assets
Cash And Cash Equivalents 30,819
Short-term Investments 39,676
Net Receivables 4,159
Inventory -4,159
Other Current Assets 7,531
Total Current Assets  (as reported)78,026
Total Current Assets  (calculated)78,026
+/-0
Long-term Assets
Property Plant Equipment 74,028
Long-term Assets Other 1,861
Long-term Assets  (as reported)77,004
Long-term Assets  (calculated)75,889
+/- 1,115

Liabilities & Shareholders' Equity

Total Current Liabilities16,293
Long-term Liabilities60,331
Total Stockholder Equity78,406
Total Current Liabilities
Short-term Debt 3,544
Accounts payable 1,741
Other Current Liabilities 9,808
Total Current Liabilities  (as reported)16,293
Total Current Liabilities  (calculated)15,093
+/- 1,200
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt60,331
Long-term Liabilities  (as reported)60,331
Long-term Liabilities  (calculated)60,331
+/-0
Total Stockholder Equity
Common Stock4
Retained Earnings -456,924
Accumulated Other Comprehensive Income -266
Other Stockholders Equity 535,592
Total Stockholder Equity (as reported)78,406
Total Stockholder Equity (calculated)78,406
+/-0
Other
Capital Stock4
Cash and Short Term Investments 70,495
Common Stock Shares Outstanding 38,594
Current Deferred Revenue1,200
Liabilities and Stockholders Equity 155,030
Net Debt 33,056
Net Invested Capital 78,406
Net Working Capital 61,733
Property Plant and Equipment Gross 74,028
Short Long Term Debt Total 63,875



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
> Total Assets 
36,112
121,684
195,715
272,064
200,057
155,030
155,030200,057272,064195,715121,68436,112
   > Total Current Assets 
31,982
117,225
176,119
249,122
122,370
78,026
78,026122,370249,122176,119117,22531,982
       Cash And Cash Equivalents 
8,242
114,504
157,954
60,789
94,746
30,819
30,81994,74660,789157,954114,5048,242
       Short-term Investments 
22,371
0
14,663
179,296
22,287
39,676
39,67622,287179,29614,663022,371
       Net Receivables 
38
282
395
4,630
318
4,159
4,1593184,63039528238
       Other Current Assets 
1,331
2,439
3,502
188,333
5,337
7,531
7,5315,337188,3333,5022,4391,331
   > Long-term Assets 
4,130
4,459
19,596
22,942
77,687
77,004
77,00477,68722,94219,5964,4594,130
       Property Plant Equipment 
3,790
4,143
5,771
19,831
43,015
74,028
74,02843,01519,8315,7714,1433,790
       Long Term Investments 
0
0
10,799
0
31,042
0
031,042010,79900
       Other Assets 
340
316
3,026
3,111
3,630
0
03,6303,1113,026316340
> Total Liabilities 
92,679
4,668
8,763
30,007
45,128
76,624
76,62445,12830,0078,7634,66892,679
   > Total Current Liabilities 
2,744
4,562
7,947
17,418
16,899
16,293
16,29316,89917,4187,9474,5622,744
       Short-term Debt 
51
47
0
-800
0
3,544
3,5440-80004751
       Accounts payable 
609
1,307
2,133
5,216
3,352
1,741
1,7413,3525,2162,1331,307609
       Other Current Liabilities 
2,084
3,208
5,814
12,202
13,547
9,808
9,80813,54712,2025,8143,2082,084
   > Long-term Liabilities 
89,935
106
816
12,589
28,229
60,331
60,33128,22912,58981610689,935
       Long term Debt Total 
144
100
53
0
0
0
00053100144
       Capital Lease Obligations 
195
147
53
4
0
63,875
63,8750453147195
       Other Liabilities 
81
6
763
12,585
28,229
0
028,22912,585763681
> Total Stockholder Equity
-56,567
117,016
186,952
242,057
154,929
78,406
78,406154,929242,057186,952117,016-56,567
   Retained Earnings -456,924-359,767-250,441-164,106-96,622-58,682
   Accumulated Other Comprehensive Income 
-14
-4
16
58
-102
-266
-266-1025816-4-14
   Capital Surplus 
2,129
3,593
351,039
492,436
514,794
0
0514,794492,436351,0393,5932,129
   Treasury Stock000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-78,377
Operating Income-78,377-78,377
 
Operating Expense (+$)
Research Development50,541
Selling General Administrative27,836
Selling And Marketing Expenses-
Operating Expense78,37778,377
 
Net Interest Income (+$)
Interest Income1,663
Interest Expense--
Other Finance Cost-0
Net Interest Income1,663
 
Pretax Income (+$)
Operating Income-78,377
Net Interest Income1,663
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-97,756-57,335
EBIT - interestExpense = 0
-97,756
-97,756
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--97,756
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-97,756
Tax Provision-0
Net Income From Continuing Ops-97,756-97,756
Net Income-97,756
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-21,042-1,663
 

Technical Analysis of Atreca
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Atreca. The general trend of Atreca is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Atreca's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Atreca Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.102 < 0.2114 < 0.2301.

The bearish price targets are: 0.066 > 0.052.

Tweet this
Atreca Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Atreca Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Atreca Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Atreca Inc. The current macd is -0.03111578.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Atreca price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Atreca. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Atreca price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Atreca Inc Daily Moving Average Convergence/Divergence (MACD) ChartAtreca Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Atreca Inc. The current adx is 38.21.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Atreca shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Atreca Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Atreca Inc. The current sar is 0.05514681.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Atreca Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Atreca Inc. The current rsi is 35.96. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Atreca Inc Daily Relative Strength Index (RSI) ChartAtreca Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Atreca Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Atreca price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Atreca Inc Daily Stochastic Oscillator ChartAtreca Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Atreca Inc. The current cci is -16.52838075.

Atreca Inc Daily Commodity Channel Index (CCI) ChartAtreca Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Atreca Inc. The current cmo is -21.73010255.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Atreca Inc Daily Chande Momentum Oscillator (CMO) ChartAtreca Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Atreca Inc. The current willr is -37.5.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Atreca is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Atreca Inc Daily Williams %R ChartAtreca Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Atreca Inc.

Atreca Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Atreca Inc. The current atr is 0.01876759.

Atreca Inc Daily Average True Range (ATR) ChartAtreca Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Atreca Inc. The current obv is 404,644,366.

Atreca Inc Daily On-Balance Volume (OBV) ChartAtreca Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Atreca Inc. The current mfi is 57.95.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Atreca Inc Daily Money Flow Index (MFI) ChartAtreca Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Atreca Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-17CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-16MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-05RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Atreca Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Atreca Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.964
Ma 20Greater thanMa 500.085
Ma 50Greater thanMa 1000.189
Ma 100Greater thanMa 2000.205
OpenGreater thanClose0.075
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Atreca with someone you think should read this too:
  • Are you bullish or bearish on Atreca? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Atreca? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Atreca Inc

I send you an email if I find something interesting about Atreca Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Atreca Inc.

Receive notifications about Atreca Inc in your mailbox!